ALL HYPOTHESES
Repurposing candidates for dasatinib
ALS 1
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| Src | amyotrophic lateral sclerosis | 0.208 | Mid | partial evidence | none |
Alzheimer 1
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| Src | Vascular dementia | 0.208 | Mid | novel signal | none |